| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |